NK Cells Expressing Interleukin-21 Show Promising Antitumor Activity in Glioblastoma Cells
August 13, 2024
August 13, 2024
HOUSTON, Texas, Aug. 13 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research from The University of Texas MD Anderson Cancer Center.
The preclinical findings, published today in Cancer Cell, represent the first ev . . .
Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research from The University of Texas MD Anderson Cancer Center.
The preclinical findings, published today in Cancer Cell, represent the first ev . . .